The role of ethnicity in willingness to participate in rheumatoid arthritis clinical trials
Koehn, C.L.
Journal of Rheumatology 32(12): 2283-2284
2005
ISSN/ISBN: 0315-162X PMID: 16331749 Document Number: 590964
Document emailed within 1 workday
Related Documents
Lee, S.J.; Lenert, L.; Weisman, S.; Kavanaugh, A. 2005: Factors affecting rheumatoid arthritis patients' decisions to participate in clinical trials Journal of Rheumatology 32(12): 2317-2325Li, Q.; Luo, F.; Zhou, Z.; Li, S.; Liu, Y.; Li, D.; Shi, W.; Raymond, H.F.; Ruan, Y.; Shao, Y. 2010: Willingness to participate in HIV vaccine clinical trials among Chinese men who have sex with men Vaccine 28(29): 4638-4643
Durant, R.W.; Legedza, A.T.; Marcantonio, E.R.; Freeman, M.B.; Landon, B.E. 2011: Willingness to participate in clinical trials among African Americans and whites previously exposed to clinical research Journal of Cultural Diversity 18(1): 8-19
Dong, Y.; Shen, X.; Guo, R.; Liu, B.; Zhu, L.; Wang, J.; Zhang, L.; Sun, J.; Zhang, X.; Xu, J. 2014: Willingness to participate in HIV therapeutic vaccine trials among HIV-infected patients on ART in China Plos one 9(11): E111321
Chakrapani, V.; Newman, P.A.; Singhal, N.; Jerajani, J.; Shunmugam, M. 2012: Willingness to participate in HIV vaccine trials among men who have sex with men in Chennai and Mumbai, India: a social ecological approach PLOS one 7(12): E51080
Suhadev, M.; Nyamathi, A.M.; Swaminathan, S.; Suresh, A.; Venkatesan, P. 2009: Factors associated with willingness to participate in HIV vaccine trials among high-risk populations in South India Aids Research and Human Retroviruses 25(2): 217-224
Mbunda, T.; Bakari, M.; Tarimo, E.A.M.; Sandstrom, E.; Kulane, A. 2014: Factors that influence the willingness of young adults in Dar es Salaam, Tanzania, to participate in phase I/Ii HIV vaccine trials Global Health Action 7: 22853
Moodley, K.; Barnes, J.; van Rensburg, E.J.; Myer, L. 2002: Willingness to participate in South African HIV vaccine trials--concerns of medical professionals in the Western Cape South African Medical Journal 92(11): 904-906
Steffanie, A. Strathdee; Robert, S. Hogg; Peter, G. A. Cornelisse; Stephen, L. Martindale; Susan, L. Currie; Michael, V. O'Shaughnessy; Martin, T. Schechter 2000: Factors Associated with Willingness to Participate in HIV Vaccine Trials Among HIV-Negative Injection Drug Users and Young Gay and Bisexual Men Aids and Behavior 4(3): 271-278
Aliyu, G.; Mohammad, M.; Saidu, A.; Mondal, P.; Charurat, M.; Abimiku, A'le.; Nasidi, A.; Blattner, W. 2010: HIV infection awareness and willingness to participate in future HIV vaccine trials across different risk groups in Abuja, Nigeria Aids Care 22(10): 1277-1284
Ruzagira, E.; Wandiembe, S.; Bufumbo, L.; Levin, J.; Price, M.A.; Grosskurth, H.; Kamali, A. 2009: Willingness to participate in preventive HIV vaccine trials in a community-based cohort in south western Uganda Tropical Medicine and International Health: Tm and Ih 14(2): 196-203
Baldini, C.; Delle Sedie, A.; Bombardieri, S. 2005: From clinical trials to the bedside: how can we treat patients with rheumatoid arthritis and concurrent morbidities who are generally excluded from randomised controlled clinical trials? Clinical and Experimental Rheumatology 23(6): 893-904
Mbunda, T; Bakari, M; Tarimo, E; Sandstrom, E; Kulane, A 2014: Factors that Influence the Willingness of Young Adults to Participate in Early Vaccine Trials and Contraceptive Practices in Dar es Salaam, Tanzania Aids Research and Human Retroviruses 30(S1): A247-A247
Kiwanuka, N.; Ssetaala, A.; Mpendo, J.; Wambuzi, M.; Nanvubya, A.; Sigirenda, S.; Nalutaaya, A.; Kato, P.; Nielsen, L.; Kaleebu, P.; Nalusiba, J.; Sewankambo, N.K. 2013: High HIV-1 prevalence, risk behaviours, and willingness to participate in HIV vaccine trials in fishing communities on Lake Victoria, Uganda Journal of the International Aids Society 16: 18621
Asiki, G.; Abaasa, A.; Ruzagira, E.; Kibengo, F.; Bahemuka, U.; Mulondo, J.; Seeley, J.; Bekker, L.-G.; Delany, S.; Kaleebu, P.; Kamali, A. 2013: Willingness to participate in HIV vaccine efficacy trials among high risk men and women from fishing communities along Lake Victoria in Uganda Vaccine 31(44): 5055-5061
Bellamy, N.; Anastassiades, T.P.; Buchanan, W.W.; Davis, P.; Lee, P.; McCain, G.A.; Wells, G.A.; Campbell, J. 1991: Rheumatoid arthritis antirheumatic drug trials. II. Tables for calculating sample size for clinical trials of antirheumatic drugs Journal of Rheumatology 18(12): 1901-1907
Kondo, H. 1997: Disease activity measures for rheumatoid arthritis clinical trials Ryumachi 37(6): 825-831
Strand, V.; Scott, D.L.; Panayi, G.S. 1994: Evaluating biologic agents in rheumatoid arthritis: a framework for clinical trials Journal of Rheumatology 21(8): 1390-1392
Pham, B.; Cranney, A.; Boers, M.; Verhoeven, A.C.; Wells, G.; Tugwell, P. 1999: Validity of area-under-the-curve analysis to summarize effect in rheumatoid arthritis clinical trials Journal of Rheumatology 26(3): 712-716
van der Heide, A.; Jacobs, J.W.; Schenk, Y.; Bijlsma, J.W. 1994: Endpoint measures in rheumatoid arthritis clinical trials: group summary and individual patient analysis Journal of Rheumatology 21(12): 2195-2199